Targeting the Undrugged 2020 | Kisaco Research

Developing Novel Therapeutics through Translation of Previously Undrugged Targets

Register
VIRTUAL CONGRESS | EDT Timezone
20-23 October, 2020

Since the emergence of PROTACs as technologies for targeting protein degradation, over 50 proteins have been targeted successfully with several entering the clinic for cancer treatment. There is promise that the 85% of proteins that were for a long time regarded as undruggable, will soon be fair game, but it isn’t just protein degradation that PROTACs have their application in targeting.

We've gone virtual!

Kisaco Research is committed to providing attendees across all of our events with the best possible experience, it’s for this reason we’ve decided to go digital and embrace the amazing new technology that enables us to deliver a virtual event.

Why Attend

With up to 85% of the human proteome currently undrugged, a new wave of technology is arriving, there is a scientific environment that is primed for innovation in targeting undrugged targets.

Development of these technologies has seen millions of dollars of investment and with different approaches quickly thrust into the limelight following recent success stories, lessons are becoming increasingly valuable across research.

Introducing Targeting the Undrugged, a virtual summit taking place across Oct 20th - 23rd. Tune in to join leading global pharmaceutical companies, biotechs and academics to explore the latest research and case studies, take away actionable insights including:

  • Clinical study data on small molecule modalities targeting oncogenic transcription factors
  • Novel strategies for targeting RNA through computational studies
  • Leading insights on target identification for protein misfolding product development
  • Develop analogous small molecule approaches to PROTACS used in protein degradation and apply cross speciality
  • Translate the latest transcription factor research into druggable approaches for safe and efficacious therapeutics
  • Move from disease treatment to prevention through RNA targeting
  • Promoting Strategies for Cross Speciality learnings for the undrugged space
  • Validate targets and their role in protein conformational disease and accelerate their translation into the clinic
15+
Leading speakers
100+
Global attendees
4
days of content
Virtual Summit

Industry leading Speakers

 

Rey Deshaies

Senior VP, Global Research
Amgen

Rey Deshaies

Senior VP, Global Research
Amgen

Rey Deshaies

Senior VP, Global Research
Amgen
 

Matt Disney

Scientific Founder
Expansion Therapeutics

Matt Disney

Scientific Founder
Expansion Therapeutics

Matt Disney

Scientific Founder
Expansion Therapeutics
 

Jane Withka

Director and Collaborations Lead in Medicine Design
Pfizer

Jane Withka

Director and Collaborations Lead in Medicine Design
Pfizer

Jane Withka

Director and Collaborations Lead in Medicine Design
Pfizer
 

Charles Lin

Vice President of Biology
Kronos Bio, Inc.

Charles Lin

Vice President of Biology
Kronos Bio, Inc.

Charles Lin

Vice President of Biology
Kronos Bio, Inc.
 

Steve Bellon

SVP, Drug Discovery
Foghorn Therapeutics

Steve Bellon

SVP, Drug Discovery
Foghorn Therapeutics

Steve Bellon

SVP, Drug Discovery
Foghorn Therapeutics
 

Eric Fischer

Assistant Professor of Biological Chemistry
Harvard Medical School

Eric Fischer, Ph.D. is Assistant Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and a Principal Investigator in the Department of Cancer Biology at Dana-Farber Cancer Institute. His research focuses on understanding the complex mechanisms that underlie function and regulation of multi-component ubiquitin ligases and their role in disease. His work further focuses on new therapeutic approaches such as targeted protein degradation.

Eric Fischer

Assistant Professor of Biological Chemistry
Harvard Medical School

Eric Fischer

Assistant Professor of Biological Chemistry
Harvard Medical School

Eric Fischer, Ph.D. is Assistant Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and a Principal Investigator in the Department of Cancer Biology at Dana-Farber Cancer Institute. His research focuses on understanding the complex mechanisms that underlie function and regulation of multi-component ubiquitin ligases and their role in disease. His work further focuses on new therapeutic approaches such as targeted protein degradation. He co-directs the DFCI Center for Protein Degradation and has been recognized for his pioneering work on the structure of cereblon and the mechanism of action of thalidomide.

 

Joey Azofeifa

Chief Executive Officer
Arpeggio Bio

Joey Azofeifa

Chief Executive Officer
Arpeggio Bio

Joey Azofeifa

Chief Executive Officer
Arpeggio Bio
 

Dr Kamal Azzaoui

CEO / Co-founder
Saverna Therapeutics AG

Saverna Therapeutics’ main aim is to discover and develop new molecules for therapeutically areas such inflammation, oncology and infectious diseases. They use a platform based on Fragment Screening using NMR coupled with Machine Learning to identify molecules targeting none coding RNAs.

Dr Kamal Azzaoui

CEO / Co-founder
Saverna Therapeutics AG

Dr Kamal Azzaoui

CEO / Co-founder
Saverna Therapeutics AG

Saverna Therapeutics’ main aim is to discover and develop new molecules for therapeutically areas such inflammation, oncology and infectious diseases. They use a platform based on Fragment Screening using NMR coupled with Machine Learning to identify molecules targeting none coding RNAs.

 

Professor François Fuks

Director
Université libre de Bruxelles and Epic Therapeutics

Professor François Fuks

Director
Université libre de Bruxelles and Epic Therapeutics

Professor François Fuks

Director
Université libre de Bruxelles and Epic Therapeutics
 

Dr Razvan Nutiu

Senior Investigator
Novartis

Dr Razvan Nutiu

Senior Investigator
Novartis

Dr Razvan Nutiu

Senior Investigator
Novartis
 

Revital Levin

VP – Development
Anima Bio

Revital Levin

VP – Development
Anima Bio

Revital Levin

VP – Development
Anima Bio
 

Poulikos Poulikakos

Principle Investigator
Icahn School of Medicine

Poulikos Poulikakos

Principle Investigator
Icahn School of Medicine

Poulikos Poulikakos

Principle Investigator
Icahn School of Medicine
 

Aubin Michalon

Principle Scientist
Neurimmune

Aubin Michalon

Principle Scientist
Neurimmune

Aubin Michalon

Principle Scientist
Neurimmune
 

Neil Cashman

CSO
ProMIS Neurosciences

Neil Cashman

CSO
ProMIS Neurosciences

Neil Cashman

CSO
ProMIS Neurosciences
 

Behnam Nabet

Research Fellow
Dana-Farber Cancer Institute

Behnam Nabet

Research Fellow
Dana-Farber Cancer Institute

Behnam Nabet

Research Fellow
Dana-Farber Cancer Institute

MAKE THE MOST OF YOUR DIGITAL EXPERIENCE

Tailor Your Agenda – with sessions spanning across multiple days, design your own agenda based on who you want to hear from and what will be most useful to your business.
Improved Audience Visibility – you can see exactly who is registered to attend the event and when they’re online – make that valuable connection in real-time!
On-Demand Content – missed a session or couldn’t tune in that day? That’s fine, sessions will be available to listen to for 2 months post event. That also means you can listen to your favourite speaker multiple times.
High Quality Speakers – this doesn’t change, whether we run a live event or a virtual one, we recruit industry leading, insightful speakers to inspire.
More Networking Opportunities – do you sometimes miss the one person you were hoping to meet at live events? With virtual events you can instant message them, add time into their diary, and email them, making target lead gen easier than ever!
Get More Involved – virtual events offer many more interactive opportunities than live events; participate in live polls, live Q&A and live panel discussions – helping you build your personal brand and your business connections.
Save Time & Money – tune into an event from the comfort of your own home, no need to travel overseas, spend time away from loved ones and spend your company's money! This makes lead gen and knowledge sharing much more cost efficient.
Increased Content – we can run more sessions at one time without the constraints of venue capacities, meaning we can provide you with more valuable content in one go.
Diverse Branding Opportunities – for those looking to partner on the virtual events, there are lots of branding opportunities through different booth formats, banners, logo placement, thought leadership etc.
Insights – using analytics, we can help you benchmark and stay head of industry trends. We can  also share audience insights on job titles, seniority and geography of attendees, so you know this is the right event to match your business needs.

Become a Sponsor

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

Download the Agenda

Following the success of our previous events, Targeting RNA, Transcription Factor Drug Development and Protein Degration, please complete your details to download the preview agenda for the upcoming Targeting the Undrugged Summit. A full agenda will be launched in the coming weeks, providing more detailed abstracts of each session.

front_cover.png

Agenda Preview

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Friday, July 31, 2020 to Friday, August 28, 2020
Academics, Students & Post-Doctoral Researchers
$299
Super early bird rate ends August 28th - save $200
This pass will give you access to all live content, 1-2-1 meetings and on-demand content across the 4 day event.
You will also have the ability to book 1-2-1 meetings throughout the event.
Friday, July 31, 2020 to Friday, August 28, 2020
Pharma & Biotech
$599
Super early bird rate ends Aug 28th - save $400
This pass will give you access to all live content, 1-2-1 meetings and on-demand content across the 4 day event.
You will also have the ability to book 1-2-1 meetings throughout the event.
To increase your brand presence, contact Chris Stefanov: [email protected]
Friday, July 31, 2020 to Friday, August 28, 2020
Service Providers, CROs & Vendors
$799
Super early bird rate ends August 28th - save $400
This pass will give you access to all live content, 1-2-1 meetings and on-demand content across the 4 day event.
You will also have the ability to book 1-2-1 meetings throughout the event.
To increase your brand presence, contact Chris Stefanov: [email protected]
Preparing registration...

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.